SANJIVANI PARANTERAL
Back to Income Statement
|
SANJIVANI PARANTERAL Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹70 Cr | ₹54 Cr | ₹35 Cr | ₹31 Cr | ₹25 Cr |
What is the latest Revenue of SANJIVANI PARANTERAL ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹70 Cr |
| Mar2024 | ₹54 Cr |
| Mar2023 | ₹35 Cr |
| Mar2022 | ₹31 Cr |
| Mar2021 | ₹25 Cr |
How is Revenue of SANJIVANI PARANTERAL Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹70 Cr | 28.83 | |
| Mar2024 | ₹54 Cr | 53.30 | |
| Mar2023 | ₹35 Cr | 15.94 | |
| Mar2022 | ₹31 Cr | 21.96 | |
| Mar2021 | ₹25 Cr | - | |
Compare Revenue of peers of SANJIVANI PARANTERAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SANJIVANI PARANTERAL | ₹237.5 Cr | -1.4% | 7.6% | -24.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹428,185.0 Cr | 3.5% | 12.3% | 5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,766.0 Cr | 2.8% | 7.2% | 7.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,923.0 Cr | 3.8% | 12.1% | 42.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,081.0 Cr | 3% | 9.1% | 11.6% | Stock Analytics | |
| CIPLA | ₹109,680.0 Cr | 1.2% | 2.8% | -9.1% | Stock Analytics | |
SANJIVANI PARANTERAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SANJIVANI PARANTERAL | -1.4% |
7.6% |
-24.8% |
| SENSEX | -0.3% |
-0.1% |
8.3% |
You may also like the below Video Courses